- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Founded in 2005, Laurus Labs is a research-driven pharmaceutical and biotechnology company having a global leadershipposition in select Active Pharmaceutical Ingredients (APIs) including anti-retroviral, oncology drugs (incl High Potent APIs), Cardiovascular, and Gastro therapeutics. They also offer integrated CMO and CDMO services to Global Innovators from Clinical phase drug development to commercial manufacturing.Laurus employs 6500+ people, including around 1050+ scientists at more than 11 facilities approved by global agencies USFDA, WHO-Geneva, Japan-PDMA, UK-MHRA, EMA, TGA etc.
Laurus Labs reported strong Q1 FY27 results with revenues at INR 2,026 Cr (+29% YoY), EBITDA at INR 644 Cr (31.8% margin), and PAT at INR 368 Cr. CDMO business surged 69% to INR 835 Cr, with 55% from commercial supplies. Affordable Medicines grew 10% to INR 1,156 Cr. Management...